Pallas Health NAD+ prices
6 figures read September 2026.
Pallas Health publishes $79–$89 for NAD+ as a first-period price and never says what it charges afterwards, which makes the headline number the least useful kind of figure in this index for working out what a year costs.
What Pallas Health publishes
Pallas Health publishes only a first-month or first-order price, and never says what it charges afterwards. Of the 3 sellers in this index that fall in the same bucket, that puts it with the 3% of the roster that publishes this shape of number rather than another one. A standing rate charged on a calendar month is the only figure this site treats as a monthly price, and 60 of the 106 sellers in this index — including this one — do not publish one.
The figure above is a first period only, “first month*”. This site never prints a price without that qualifier, on any surface, because the same number means a different thing depending on it — and in this corpus the same seller often prints several.
Every figure Pallas Health publishes — 6 figures, read September 2026
| Figure | What it is | Cycle, in their words | Route | Dose | Read |
|---|---|---|---|---|---|
| $79 | first period | “first month*” | Nasal | Not stated | September 2026 |
| $567 | prepay total | “every 12 weeks” | Nasal | Not stated | September 2026 |
| $189 | unresolved | “/mo avg” | Nasal | Not stated | September 2026 |
| $89 | first period | “first month*” | SubQ | Not stated | September 2026 |
| $597 | prepay total | “every 12 weeks” | SubQ | Not stated | September 2026 |
| $199 | unresolved | “/mo avg” | SubQ | Not stated | September 2026 |
In Pallas Health’s own words
- $79 first period
The page says: “NAD+ NASAL SPRAY $79 first month* then $189/mo avg”
The asterisk resolves on the same page to: '*Plan price includes provider care, ongoing check-ins, and care-team messaging — no separate membership fee.' Paired on the page with the $567/12-week figure recorded separately below.
Read from https://www.pallashealth.co/treatments/nad on September 2026.
- $567 prepay total
The page says: “Nasal spray: $79 for your first month, then $567 every 12 weeks ($189/mo average).”
This is the recurring charge the page states for the nasal route: 12 weeks, not a month. The page adds 'Auto-renews unless canceled — cancel anytime.' Same sentence appears twice (footnote and FAQ answer), identically.
Read from https://www.pallashealth.co/treatments/nad on September 2026.
- $189 unresolved
The page says: “then $189/mo avg”
Not resolved. The seller's own monthly AVERAGE of the $567/12-week charge, published as such ('$189/mo avg', '($189/mo average)'). It is not an amount ever billed and must never be ranked as a monthly price or added to the $567.
The seller's own monthly AVERAGE of the $567/12-week charge, published as such ('$189/mo avg' on the card, '($189/mo average)' in the footnote and FAQ). It is not a separate amount billed — recorded because the seller publishes it, and must not be added to $567.
Read from https://www.pallashealth.co/treatments/nad on September 2026.
- $89 first period
The page says: “NAD+ INJECTION $89 first month* then $199/mo avg”
Route is the page's own words, 'a weekly subcutaneous injection' — one of the few sellers in this batch that names it. Asterisk resolves to '*Plan price includes provider care, ongoing check-ins, and care-team messaging — no separate membership fee.'
Read from https://www.pallashealth.co/treatments/nad on September 2026.
- $597 prepay total
The page says: “Injection: $89 for your first month, then $597 every 12 weeks ($199/mo average).”
The recurring charge for the injection route: 12 weeks, not a month. 'Auto-renews unless canceled — cancel anytime.'
Read from https://www.pallashealth.co/treatments/nad on September 2026.
- $199 unresolved
The page says: “then $199/mo avg”
Not resolved. The seller's own monthly AVERAGE of the $597/12-week charge. Not an amount ever billed; do not rank it or add it to the $597.
The seller's published monthly AVERAGE of the $597/12-week charge. Not a separate amount billed — do not add it to $597.
Read from https://www.pallashealth.co/treatments/nad on September 2026.
Price disclosure score: 57 of 100
This scores what Pallas Health publishes about its price, and nothing else. It is not a rating of the product, the clinic, the prescriber or the value — this site has read a price page, not used a product. Across all 106 sellers in the index the scores run from 6 to 100, with a median of 72. Pallas Health sits 86 of 106.
| What is scored | What Pallas Health publishes | Points |
|---|---|---|
| An exact figure | The published figure is a first-period price. What the seller charges afterwards is not on the page. | 12of 30 |
| A stated cadence | A cadence is stated, but it is a first period or a per-unit price rather than the standing charge. | 10of 20 |
| Visible on the page | Every headline figure (2 figures) is printed where a reader can see it. | 20of 20 |
| A stated route | The seller states how the product is administered, in its own sentence. | 15of 15 |
| A stated dose | None of this seller's 6 figures states a dose, so no cost per milligram can be worked out from the page. | 0of 15 |
| Price disclosure score | This scores what the seller publishes about its price — not the product, the clinic, the prescriber or the value. | 57of 100 |
What Pallas Health does not publish
Each of these is a count over what was actually read, not an impression. 6 figures were read from this seller, and every sentence below is measured against that number.
- None of the 6 figures read from this seller is a standing rate charged by the calendar month.
- No dose is stated beside any of the 6 figures, so nothing on the page divides into a cost per milligram.
- 2 of 6 figures could not be resolved into a price at all. Each carries the reason on this page, and none of them is estimated, averaged or guessed at.
Figures visible to a reader on the seller’s page
6 of 6
Figures stating a dose
0 of 6
Figures that resolve to a usable price
4 of 6
Source: Counted over the 6 figures read from Pallas Health’s own pages, September 2026. Each track is that figure count.
Where Pallas Health sits
66 other sellers in this index also state a Nasal and SubQ route. Ranked with them on price disclosure, Pallas Health is 60 of 67. That is a statement about how completely each one publishes a price, and about nothing else — the figures behind those rows are different kinds of number and several of them state no dose, so they are not a like-for- like price comparison and this site does not present them as one.
Boards Pallas Health appears on
The reading record
This site has read Pallas Health once, in September 2026. A movement can only be shown between two readings taken here, so there is nothing to show yet — and a single reading is a fact about this site's record, never a statement that the seller held its price.
Figures are read from Pallas Health’s own public pages and recorded with the date. What counts as a price, and why a “from” figure is recorded as a floor rather than a rate, is set out on the editorial policy page. Prices in this category move quietly, so the figure above is what the page said on September 2026 and not a promise about today.